These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 2901023

  • 1. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES, Csernansky JG, Hollister LE.
    Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
    Prosser ES, Pruthi R, Csernansky JG.
    Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
    [Abstract] [Full Text] [Related]

  • 4. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J, Sebens JB.
    J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mesolimbic and striatal dopamine receptor supersensitivity: prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG).
    Chiu P, Rajakumar G, Chiu S, Johnson RL, Mishra RK.
    Peptides; 1985 Feb; 6(2):179-83. PubMed ID: 2863809
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptics have identical potencies in human brain limbic and putamen regions.
    Seeman P, Ulpian C.
    Eur J Pharmacol; 1983 Oct 14; 94(1-2):145-8. PubMed ID: 6140171
    [Abstract] [Full Text] [Related]

  • 9. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R, Scavone C, Camillo MA.
    Braz J Med Biol Res; 1989 Oct 14; 22(6):741-3. PubMed ID: 2620186
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW, Schwartz R, Friedhoff AJ.
    Res Commun Chem Pathol Pharmacol; 1982 Oct 14; 38(1):21-30. PubMed ID: 7146618
    [Abstract] [Full Text] [Related]

  • 12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 14; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 13. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA.
    Brain Res; 1983 May 09; 267(1):179-82. PubMed ID: 6860944
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.
    Simpson MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1986 Oct 15; 35(20):3501-6. PubMed ID: 3768037
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat.
    Angulo JA, Coirini H, Ledoux M, Schumacher M.
    Brain Res Mol Brain Res; 1991 Sep 15; 11(2):161-6. PubMed ID: 1661813
    [Abstract] [Full Text] [Related]

  • 19. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
    Jenner P, Rupniak NM, Hall MD, Dyer R, Leigh N, Marsden CD.
    Eur J Pharmacol; 1981 Nov 19; 76(1):31-6. PubMed ID: 6119220
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.